… of the antibody response against SARS-CoV-… antibody recognition of the SARS-CoV-2
RBD. Three major epitopes on the RBD are recognized by the currently characterized SARS-CoV-…

… These RBD antibodies ameliorate SARS-CoV-2 infection in mice … antibody recognition
and neutralization highlights both potent single antibodies and stereotypic classes of antibodies …

… in antibody therapeutics and vaccines that induce antibodies to severe acute respiratory …
coronavirus 2 (SARS-CoV-2). Many potently neutralizing anti-SARS-CoV-2 antibodies target the …

… to understand the molecular basis for immune recognition of SARS-CoV-2 spike (S) … for
SARS-CoV-2 neutralization, we determined the structures of two human monoclonal antibodies …

… Moreover, S309 can broadly neutralize sarbecoviruses, including all currently identified
SARS-CoV-2 VOC, as the epitope sequences recognized by S309 are highly conserved among …

… vary according to recognition epitopes. Several potent … that have antibody-escape mutations
and the potential for antibody-… representative SARS-CoV-2 neutralizing antibodies that have …

… Fabs, revealing recognition of both S1 A and RBD epitopes on SARS-CoV-2 … SARS-CoV-2
spike mutations. Overall, our studies structurally define a recurrent anti-SARS-CoV-2 antibody …

… First, neutralizing monoclonal antibodies that target the SARS-CoV-2 RBM can prevent the
virus from binding to ACE2, and are therefore promising antiviral drugs. Our structure has laid …

… infection of authentic SARS-CoV-2 and recombinant VSV/SARS-CoV-2 viruses. We …
SARS-CoV-2 S neutralization escape variants. Mechanistic studies showed that these antibodies …

… ” antibodies revealed an NTD epitope that is recurrently mutated among emerging SARS-CoV-2 …
and other non-RBD plasma antibodies are prevalent and have implications for SARS-…